n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone has been researched along with spiperone in 1 studies
Studies (n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone) | Trials (n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone) | Recent Studies (post-2010) (n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone) | Studies (spiperone) | Trials (spiperone) | Recent Studies (post-2010) (spiperone) |
---|---|---|---|---|---|
15 | 0 | 0 | 2,944 | 13 | 85 |
Protein | Taxonomy | n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone (IC50) | spiperone (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 10 | |
D(2) dopamine receptor | Homo sapiens (human) | 0.0008 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.097 | |
D(4) dopamine receptor | Homo sapiens (human) | 0.0005 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.097 | |
Histamine H1 receptor | Cavia porcellus (domestic guinea pig) | 0.097 | |
D(3) dopamine receptor | Homo sapiens (human) | 0.0635 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.097 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0001 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.955 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crocker, AD; Russell, RW | 1 |
1 other study(ies) available for n-(4-(2-chloroethylmethylamino)-2-butynyl)-2-pyrrolidone and spiperone
Article | Year |
---|---|
Pretreatment with an irreversible muscarinic agonist affects responses to apomorphine.
Topics: Animals; Apomorphine; Brain; Cholinergic Fibers; Male; Motor Activity; Pyrrolidinones; Quinuclidinyl Benzilate; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Muscarinic; Spiperone; Stereotyped Behavior | 1990 |